Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 250

Clinical Trials Chronic Pain Cannabinoids Patients 250

Veriheal

FEBRUARY 3, 2021

The study published in the Annals of Internal Medicine found that there is an increasing number of cannabis consumption by adults over the age of 55. . This is a major win for cancer patients as it provides an alternative treatment that is not effective by means of potent chemicals. . A Cannabis Strain That Kills Cancer Cells.

Consumption 52

Consumption Safety THC Cannabis 52

Veriheal

DECEMBER 15, 2021

Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. A literature review of existing research suggested that CBD specifically may hold therapeutic potential for the treatment of insomnia.

Sleep 98

Sleep Cannabinoids Therapy Treatment 98

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. “(Cannabis is) also used in conjunction with other medicines, either to improve their efficacy or to mitigate negative side effects. by the year 2027 , at which point the market could be worth a staggering $33.2

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

AUGUST 2, 2021

In 2020, founders Daniel Goldberg , Tim Schlidt and Tony Eisenberg partnered to form Palo Santo, and formally launched the venture capital fund in 2021. Having seen the enormous therapeutic potential of psychedelic medicines years ago, the partners have been active as early participants and investors in the emerging industry.

Research and Development 98

Research and Development Therapy Collective Treatment 98

The Cannigma

JUNE 13, 2021

It is possible that when used for medicinal purposes and with low-THC strains that are less likely to lead to CUD, cannabis may not have a negative impact on sleep,” the researchers stated. Countless people use cannabis at least in part because it can make it easier to fall asleep , making it a potentially effective treatment for insomnia.

Sleep 137

Sleep Data Cannabis THC 137

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% from 2020 to 2030 and generate revenue of $151.7

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

MARCH 22, 2020

A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza. 9:46 AM – Mar 19, 2020.

THC 59

THC Clinical Trials Data Consumption 59

Healer

MARCH 26, 2021

Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. It’s estimated that 2020 spending was about $48 million. . Opioids are a good medicine.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Cannabis Law Report

OCTOBER 15, 2021

The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., New data supporting the use of machine learning and electronic health records to predict DN in patients with diabetes. “In

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial. SOURCE InMed Pharmaceuticals Inc.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

NOVEMBER 9, 2021

(“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) (Original Source), a leader in new medicines and treatments for a modern world, today announced the official, completed acquisition of Ketamine Wellness Centers Arizona LLC (“KWC”), becoming the largest chain of wellness centers providing ketamine treatments in the U.S.

Treatment 52

Treatment Therapy Media Access 52

Cannabis Law Report

DECEMBER 6, 2021

–(BUSINESS WIRE)–Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced the appointment of Jeff W. Jacobs, Ph.D. as Chief Scientific Officer (CSO). Dr. Jacobs, who most recently served as CSO of Ardelyx, Inc.,

Research and Development 52

Research and Development Supply Chain Clinical Trials Medicine 52

The Joint Blog

FEBRUARY 24, 2021

This is not the first medicinal trial of its kind. They made it clear that no evidence is available and that there are real potential risks to treatment. On surveying medical professionals it was found that most had been asked about cannabis-based alternative treatment by their patients. Out of these respondents, 45.9%

Treatment 55

Treatment Clinical Trials Collective Patients 55

The Cannigma

JUNE 30, 2021

According to the Arkansas Department of Health’s end-of-year fiscal report for 2020 , these were the top qualifying conditions for residents of the Natural State: Condition Number of patients Percentage of total Intractable pain that doesn’t respond to other treatments for more than 6 months 19,728 32.5% Cancer 839 7.8%.

Chronic Pain 137

Chronic Pain Marijuana Conditions Patients 137

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

MARCH 9, 2022

This license expansion will further position Numinus as a recognized global research centre for natural psychedelic medicines, and supplements the current work Numinus is already undertaking on Psilocybe species and inherent synergistic compounds. Harmaline and harmalol naturally occur in B. caapi , while P. viridis , D.

Research and Development 52

Research and Development Therapy Access Medicine 52

The Blunt Truth

MAY 26, 2020

However, enforcement, as it relates to CBD products and their claimed medicinal effects on COVID-19, is becoming increasingly apparent to industry watchers. First, in early March 2020, FDA Commissioner Stephen Hahn issued a statement updating the public on the agency’s work. Federal Court Litigation.

CBD 103

CBD Hemp Programs Food 103

Cannabis Law Report

JANUARY 17, 2022

This application claims the priority date of a preceding provisional application filed with the United States Patent and Trade Office on December 31, 2020. These molecules belong to the tryptamine class of compounds that has been gaining momentum in the psychedelic medicine space in recent years.

Research and Development 52

Research and Development Pharmaceutical Access Medicine 52

Veriheal

MAY 31, 2022

According to data released by the Centers for Disease Control and Prevention , there were an estimated 2,620 opioid overdose deaths in Texas between Aug. 1, 2020, and July 31, 2021—a 43% increase from the same period a year before. Interestingly, although opioids work well for acute pain (e.g.,

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Findings based on NPDS data do not necessarily reflect the opinions of AAPCC. brownies, gummies).

THC 105

THC Pets Events Hemp 105

Canna Care Docs

DECEMBER 16, 2020

Between the pandemic and the political climate, 2020 hasn’t exactly been a walk in the park. It would feel like an out-of-body experience, except for one fact: your body is constantly reminding you of those symptoms you’ve been suffering from all this time, putting treatment on the back burner while you deal with life as we know it.

Chronic Pain 52

Chronic Pain Marijuana Clinical Trials Epilepsy 52

Cannabis Law Report

AUGUST 23, 2021

In 2020, several more FDA Warning Letters were issued for CBD products illegally marketed for pets. He added that significant data is still needed to inform policy regarding use of consumer cannabis products. She acknowledged that “FDA is considering the possibility of new legal pathways for CBD products.”.

Pets 105

Pets Hemp CBD Food 105

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial. SOURCE InMed Pharmaceuticals Inc.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Veriheal

OCTOBER 20, 2021

Data from a nationally representative sample of participants have been collected since 1975 to understand drug use trends among American young adults, and noteworthy findings are published each fall. In 2020, Oregon became the first state in America to decriminalize psychedelics in small amounts. Talk about mixed signals.

Therapy 98

Therapy Microdosing Decriminalization Consumption 98

CannaMD

SEPTEMBER 15, 2020

Where can you use your medicine and when are you at risk of getting arrested? SHORT ANSWER: In November 2016, the Florida Medical Marijuana Legalization Initiative (known as Amendment 2 ) legalized medical marijuana treatment in Florida. Check out CannaMD ‘s full list of medical marijuana treatment centers !).

Law 126

Law Marijuana Patients Treatment 126

Cannabis Law Report

NOVEMBER 29, 2021

We’re walking the walk and we’re taking that public health approach to this crisis.”. — New Jersey Office of the Attorney General, 2020. billion (2020 dollars) over the past decade to enforce the drug war, amounting to an average of $1.2 But we mean it. Report Overview. New Jersey Invested $11.6 New Jersey spent at least $11.6

Policy 52

Policy Decriminalization Treatment History 52

Cannabis Law Report

DECEMBER 14, 2021

(NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), announced today that it is the first company to formulate medical cannabis extract vaporizer pen products in a UK-based manufacturing premises, licensed and approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office.

Extraction 52

Extraction Patients Medicine Tincture 52

Veriheal

FEBRUARY 18, 2021

Psychedelics and music have long had a love affair but now, their relationship stands to take on a more therapeutic role and Johns Hopkins University School of Medicine is here for it. The team of researchers from Johns Hopkins University School of Medicine wanted to examine how “set and setting impacts subjective and therapeutic effects”.

Therapy 52

Therapy Research and Development Collective Consumption 52

Cannabis Law Report

AUGUST 10, 2021

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98

Data Pharmaceutical Treatment Medicine 98

Veriheal

JANUARY 26, 2022

This is an example of racial disparity, defined as “the imbalances and incongruities between the treatment of racial groups” by Howard University. Fortunately, a study recently published in Social Science & Medicine discovered a solution to the racial disparity rampant in cannabis regulation: decriminalization.

Decriminalization 98

Decriminalization Data Cannabis Recreational 98

Cannabis Law Report

SEPTEMBER 20, 2019

Data indicates cannabis-containing vaping products losing market share to other cannabis products after recently reported health concerns. California’s 2019 legislative session has ended, with a number of significant cannabis and hemp bills tabled for January 2020 when the State Legislature reconvenes. International.

Vaping 40

Vaping Banking Research and Development DEA 40

CannaMD

SEPTEMBER 10, 2020

Data from the National Institute of Health indicates that younger women are more likely to use marijuana during pregnancy, with urine toxicology testing showing that 19% of pregnant women aged 18-25 screened positive for marijuana use. These numbers reflect both non-medical and medicinal marijuana use.

Marijuana 59

Marijuana Therapy Data THC 59